ParallaxIP is a specialized brokerage for robotics, therapeutics, medical device, and hardware patents. We find contrarian IP that combines disciplines in ways the market hasn't priced in yet.
3.55 million patents were filed globally last year. The vast majority of IP brokers treat them as interchangeable financial instruments. Software patents, mechanical patents, biotech patents, all run through the same generalist pipeline.
Deep tech patents are different. A patent combining robotic actuation with therapeutic delivery isn't just a mechanical claim and a pharma claim stapled together. It's a new category. And it requires someone who reads both literatures to see the value.
That's where the mispricing lives. Cross-disciplinary patents in contrarian areas, the ones that don't fit neatly into any broker's existing playbook. They get undervalued, overlooked, or bundled into portfolio sales where their individual worth disappears.
Built by deep tech investors who've evaluated hundreds of patent-rich companies across robotics, biotech, and hardware. We read the claims, not just the abstracts.
The most undervalued patents sit at the intersection of two fields. We identify IP that combines disciplines in novel ways before the market catches up.
University tech transfer offices, corporate divestitures, dormant startup portfolios. We source from channels that generalist brokers don't monitor because they lack the technical context to evaluate what they'd find.
Patent database scanning, NLP-driven claim analysis, and automated landscape mapping. Technology amplifies our domain expertise, not replaces it.
Every generational technology shift creates a window where the right patents change hands for the wrong price. We exist to close that gap.
ParallaxIP. See what others miss.